Lack of responsiveness to L-dopa in Cushing's disease.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000284:Administration, Oral; D000324:Adrenocorticotropic Hormone; D000328:Adult; D002940:Circadian Rhythm; D003480:Cushing Syndrome / Q000097:blood / Q000188:drug therapy* / Q000652:urine; D003907:Dexamethasone; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005951:Glucose Tolerance Test; D013006:Growth Hormone / Q000097:blood*; D006801:Humans; D006854:Hydrocortisone / Q000097:blood*; D007328:Insulin; D008297:Male; D008875:Middle Aged; D010648:Phenylacetates / Q000652:urine; D012636:Secretory Rate
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D007328:Insulin; D010648:Phenylacetates; D004295:Dihydroxyphenylalanine; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D013006:Growth Hormone; D006854:Hydrocortisone